; Whereas geographic availability of facilities and transportation barriers are persistent challenges to lung cancer screening; Whereas nearly 70 percent of adults are not familiar with lung cancer screening and the low-dose computed tomography scan; Whereas lung cancer is the second most commonly diagnosed cancer in veterans; Whereas veterans are 25 percent more likely to develop lung cancer compared to the general public, and, although approximately 1,000,000 to 2,000,000 veterans have an elevated risk of lung cancer and are eligible for screening, less than 3 percent of veterans get screened; Whereas Black men have the highest incidence of lung cancer and the highest mortality rate from lung cancer in the United States, and non-White individuals are 14 to 17 percent less likely to be diagnosed with lung cancer early; Whereas changes made to the United States Preventive Services Task Force lung cancer screening guidelines in 2021 increased the number of individuals in the United States who are recommended to receive screening from 8,000,000 to 14,500,000; Whereas the stigma surrounding lung cancer— (1) creates barriers to early diagnosis, treatment, and research; (2) has a detrimental impact on the quality of life of lung cancer patients; and (3) hinders funding into lung cancer risk factors unrelated to smoking; Whereas lung cancer research is leading to breakthroughs in biomarker identification and the development of immunotherapies and targeted therapies that are highly effective for some cancer subtypes, yet accessing cutting edge testing as part of the lung cancer diagnostic process can be difficult; and Whereas educational efforts can increase awareness of lung cancer and lung cancer screening among the general public, patients and their families, and health care workers, thereby increasing the early detection of lung cancer: Now, therefore, be it